News Verily plans digital ophthalmology joint venture with Santen Verily is planning a digital ophthalmology joint venture with Japan’s specialist in the field, Santen.
News Oxford Biomedica signs ophthalmology R&D deal with Santen UK biotech Oxford Biomedica and Japan’s Santen have begun an option and licence agreement to research and develop gene therapy products for an inherited retinal disease.
Partner Content Partner Content Queen's University Belfast and Santen to Present Opening Key... Ophthalmic Drugs Conference London
Events Partner Content Ophthalmic Drugs - Europe's Leading Ophthalmic Conference Ophthalmic Drugs Conference
Partner Content Partner Content Boehringer Ingelheim, Novaliq, Santen, Shire, at Europe's Le... SMi’s Leading Ophthalmic Conference
News Lilly grabs first-ever FDA nod for a sleep apnoea drug Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
